Adenosquamous Cell Carcinoma (1)

Basaloid Squamous Cell Carcinoma (1)

Squamous Cell Carcinoma of the Head and Neck (1)

Undifferentiated Carcinoma (1)

Terminated (1)

phase 1/phase 2 (1)

Dana-Farber Cancer Institute (1)

Celgene Corporation (1)

abraxane (1)

carboplatin (1)

erbitux (1)

intensity modulated radiation therapy (1)

drug (1)

radiation (1)

Other (1)

Interventional (1)

undifferentiated carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Oct 10, 2017